Answer
Durvalumab (Imfinzi) concentrate for solution for infusion must not be mixed with other medicinal products in the absence of compatibility studies.
Sources for this answer
- IMFINZI 50 mg/mL concentrate for solution for infusionAstraZeneca UK Limited · emc · SmPC §6.2 Incompatibilities · Version 38Document updated
Sources checked